Page last updated: 2024-11-12
2-aminocyclobutanecarboxylic acid
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
2-aminocyclobutanecarboxylic acid: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 13039550 |
SCHEMBL ID | 17234168 |
MeSH ID | M0538192 |
Synonyms (17)
Synonym |
---|
AKOS006339719 |
84585-77-3 |
trans-2-aminocyclobutane-1-carboxylic acid |
SCHEMBL17234168 |
cyclobutanecarboxylic acid, 2-amino-, trans- |
951173-26-5 |
(1r,2r)-2-aminocyclobutane-1-carboxylic acid |
rel-(1r,2r)-2-aminocyclobutanecarboxylic acid |
CS-0055426 |
P12531 |
rac-(1r,2r)-2-aminocyclobutane-1-carboxylic acid |
EN300-7307388 |
trans-2-aminocyclobutane-1-carboxylicacid |
2-aminocyclobutanecarboxylic acid |
cyclobutanecarboxylic acid, 2-amino-, (1r,2r)-rel- |
2-aminocyclobutanecarboxylic acid, trans- |
34RKV74RET |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 7 (87.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.72
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.72) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |